180 Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
180 Wealth Advisors's XBI Position: Q2 2026 in Review
180 Wealth Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 9.1% in Q2 2026, buying an estimated $108K and bringing the position to 9,608 shares worth $1.52M. The position accounts for 0.15% of the portfolio, ranked #148.
180 Wealth Advisors first reported a position in XBI in Q4 2023 and has held it in 11 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- 180 Wealth Advisors held 9,608 shares of State Street SPDR S&P Biotech ETF worth $1.52M as of Q2 2026.
- 180 Wealth Advisors bought 799 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $108K.
- State Street SPDR S&P Biotech ETF made up 0.15% of 180 Wealth Advisors's portfolio in Q2 2026, its #148 holding.
- 180 Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 11 quarters since.
- 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.